Timexon

Timexon is an immunomodulating medication consisting of the acetate salts of synthetic polypeptides containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine. Developed by Biocad, it is a generic version of the reference drug Copaxone. Timexon is indicated for the treatment of relapsing-remitting multiple sclerosis (RRMS) to reduce the frequency of relapses. Its mechanism involves shifting the immune response from pro-inflammatory Th1 T-cells to regulatory, anti-inflammatory Th2 T-cells that migrate to the central nervous system and suppress local inflammation. Additionally, it acts as a decoy by competing with myelin antigens for binding to major histocompatibility complex (MHC) class II molecules, thereby inhibiting the activation of myelin-reactive T-cells.

Brand names

Timexon

Other names

glatiramer acetateBCD-063BCD063BCD 063